Cat Heart Disease: The Silent Condition in a Species That Hides Pain

One in Six Cats May Have a Heart Condition -- and Show No Signs

HCM is unique among serious diseases for its ability to hide. Cats with significant cardiac thickening often have normal activity levels, eat well, and maintain weight. The heart compensates -- sometimes for years -- before decompensating in a crisis. A cat presenting in acute congestive heart failure (fluid in the chest, labored breathing, open-mouth breathing) may have had severe HCM for 2-3 years with no detectable symptoms.

This creates a genuine public health problem: cats at high risk (Maine Coons, Ragdolls, British Shorthairs, and other breeds where HCM genetic mutations have been identified) should have regular cardiac screening even when they seem perfectly healthy. An echocardiogram (cardiac ultrasound) is the only reliable way to diagnose HCM before symptoms develop.

The Emergency No Owner Expects: Sudden Hind Limb Paralysis

Aortic thromboembolism (ATE) is one of the most dramatic and terrifying presentations in feline medicine. A blood clot forms in the enlarged, poorly-contracting left atrium and lodges at the aortic trifurcation (the point where the aorta splits to supply the hind legs). Within minutes, the cat's hind legs become cold, painful, paralyzed, and cyanotic (gums may be pale or blue). The cat is in extreme pain and may vocalize or hide.

Survival rates for ATE have improved with aggressive management but remain poor: approximately 33-40% survive to discharge, and of survivors, many experience recurrence within 6 months. The decision to pursue treatment involves intensive hospitalization, pain management, anticoagulation, and a realistic conversation about prognosis -- a heart-wrenching situation made more devastating by its sudden onset in a cat that seemed healthy hours before.

Genetic Testing in Breeds -- What It Reveals and What It Misses

Two mutations in the MYBPC3 gene (A31P in Maine Coons and R820W in Ragdolls) have been identified as causes of HCM in those specific breeds. Genetic tests are available through labs including NC State's Veterinary Genetics Lab. A cat that tests negative for the breed-specific mutation is not guaranteed to be free of HCM -- other genetic variants and non-hereditary forms exist. A negative genetic test reduces risk; it doesn't eliminate it. Echocardiographic screening is still recommended even in mutation-negative cats of high-risk breeds.

For breeders, genetic testing and breeding away from positive cats is meaningful progress. The Maine Coon HCM prevalence has declined in populations where breeders have consistently screened and selected against the A31P mutation over generations.

Managing Diagnosed HCM: What the Medication Can and Cannot Do

No medication has been proven to slow HCM progression in cats. Current medical management aims to control symptoms and prevent complications. Atenolol (beta-blocker) and diltiazem (calcium channel blocker) are used for heart rate control. Furosemide diuretic manages fluid accumulation in congestive heart failure. Clopidogrel (Plavix) reduces clot formation and decreases ATE risk -- it's the only treatment with a randomized controlled trial (FATCAT study) showing significant reduction in ATE recurrence and improved survival.

Cats in compensated HCM (no fluid, stable heart size) may need no medication for years. Regular 6-12 month echocardiographic rechecks monitor disease progression and help time medication introduction optimally. A home respiratory rate monitor (counting breaths per minute when the cat is sleeping) is one of the most valuable tools for catching early fluid accumulation before a crisis -- a resting respiratory rate consistently above 30 breaths per minute warrants same-day evaluation.